Liquid Biopsy Market Forecasts CAGR of 23.2% and Industry Analysis by Biocept, Inc, Qiagen, Myriad Genetics, Inc, Janssen Diagnostics

Global Liquid Biopsy Industry 2018 Market Research Report focuses on price, sales, revenue and growth rate of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers. Second on basis of segments by manufacturers, this report focuses on the sales, price of each type, average price of Credit Insurance, revenue and market share, for key manufacturers.

The global liquid biopsy market is expected to reach USD 3798.54 Million by 2025, from USD 715.7 Million in 2017 growing at a CAGR of 23.2% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2017, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

For In depth Information Get Free Sample Copy of this Report@ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-liquid-biopsy-market

Global Liquid Biopsy Market, By Biomarker (Circulating Tumor DNA and other), By Clinical Application (Early Cancer Screening, Therapy and others), By Application (Cancer Applications & Non-Cancer Applications) By Product (Assay Kits and others), By End Users, By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)– Industry Trends and Forecast to 2025

Complete report on Global Liquid Biopsy Market Research Report 2017-2024 spread across 350 Pages, profiling Top companies and supports with tables and figures

Market Definition: Global Liquid Biopsy Market

This market report defines the market trends and forecast the upcoming opportunities and threats of the liquid biopsy market in the next 8 years. Liquid biopsy is a method for checking any cancerous cell from tumor travelling in blood stream or stretch of DNA from tumor cells present in blood. It is mainly done to diagnose the cancer in the early stage, for treatment planning, to check whether the treatment is effective or reoccurrence of cancer. Different liquid biopsy test analyze different tumor materials like DNA, RNA protein molecules. The test can be performed in different liquid fluids including blood, urine or cerebrospinal fluids. Liquid biopsy actually works as a “surveillance” that had undergone the treatment. In liquid biopsies ctDNA (circulating DNA) biopsies may help in guiding the precise medical treatment. Guardant360 is a test that analyzes around 70 cancer related genes in blood sample to recognize the mutation in ctDNA. In 2016, FDA approved a liquid biopsy test called cobas EGFR mutation test to discover EGFR mutation in ctDNA of lung cancer patients. ctDNA biopsies are convenient because they are noninvasive and are considered to be consistent. Liquid biopsy also used to track the treatment response in lymphoma patients. Though, the major issue of liquid biopsy is that they lack biomarkers for specific tumor type. In a study, Johns Hopkins University School of Medicine, Baltimore developed a liquid biopsy to test multiple genes that are mutated in common cancers. Recently, John Hopkins Research Institute discovered Cancereek which overcame the disadvantage of general liquid biopsy test.

Key Questions Answered in Global Liquid Biopsy Market Report:-

Our Report offers:-

• What will the market growth rate, Overview and Analysis by Type of Global Liquid Biopsy Market in 2025?

• What are the key factors driving, Analysis by Applications and Countries Global Liquid Biopsy Market?

• What are Dynamics, This Overview Includes Analysis of Scope, and price analysis of top Vendors Profiles of Global Liquid Biopsy Market?

• Who are Opportunities, Risk and Driving Force of Global Liquid Biopsy Market?

• Who are the opportunities and threats faced by the vendors in Global Liquid Biopsy Market? Business Overview by Type, Applications, Gross Margin and Market Share

• What are the Global Liquid Biopsy Market opportunities, market risk and market overview of the Market?

Request for Detailed TOC: http://databridgemarketresearch.com/toc/?dbmr=global-liquid-biopsy-market

Top Key Players:

• Biocept, Inc
• Qiagen
• F. Hoffmann-La Roche AG
• Bio-Rad Laboratories, Inc.
• Myriad Genetics, Inc
• Janssen Diagnostics
• Trovagene
• Guardant Health, Inc
• Grail, Inc
• MDxHealth
• Fraunhofer-Gesellschaft
• Horizon Discovery Group Plc
• Illumina, Inc
• Cynvenio Biosystems, Inc
• Diagnologix
• Exosome Diagnostics
• AccuraGen
• Agena Bioscience
• Bio-Rad Laboratories, Inc
• CellMax Life
• Chronix Biomedical
• Clearbridge Biomedics Pte Ltd
• Circulogene
• Cynvenio Biosystems, Inc
• Epic Sciences
• Freenome Inc
• Genomic Health
• Natera, Inc
• OncoCyte Corporation
• Pathway Genomics
• Personal Genome Diagnostics, Inc
• RainDance Technologies, Inc
• Sequenom
• Sysmex
• Thermo Fisher Scientific
• Transgenomic
• Vermillion
• WaveSense
• among others.

Major Market Drivers and Restraints:

• Research and development in development of biomarkers for liquid biopsies
• Government support in pharmaceutical and biotechnology industry
• Increased in the number of cancer patients
• Preference of noninvasive procedures over invasive procedures of treatment
• Advancement in technology for developing better applications.
• Downward pricing pressure owing to its commodity nature

Avail 10% Instant Discount on Purchase of This Report Mail @ sopan.gedam@databridgemarketresearch.com

Key Reasons to Purchase:

• To gain insightful analyses of the market and have comprehensive understanding of the Global Liquid Biopsy Market and its commercial landscape.

• Assess the Liquid Biopsy production processes, major issues, and solutions to mitigate the development risk.

• To understand the most affecting driving and restraining forces in the Liquid Biopsy Market and its impact in the Global market.

• Learn about the market strategies that are being adopted by leading respective organizations.

• To understand the future outlook and prospects for Global Liquid Biopsy Market.

Inquire Before Buying @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-liquid-biopsy-market

Customize report of "Global Liquid Biopsy Market" as per customers requirement also available.

Market Segmentations:

Global Liquid Biopsy Market is segmented on the basis of
• Biomarker
• Clinical Application
• Product and Services
• Application
• End users
• Geography

Market Segmentations in Details:

On the basis of Biomarker, the global liquid biopsy market is segmented into circulating tumor cells, circulating tumor DNA, cell-free DNA, extracellular vesicle, and other circulating biomarker.

On the basis of Clinical Application, the global liquid biopsy market is segmented into early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring.

On the basis of Product and Services, the global liquid biopsy market is segmented into assay kits, instruments and services.

On the basis of Application, the global liquid biopsy market is segmented into cancer applications and non-cancer applications.

On the basis of End Users, the global liquid biopsy market is segmented into hospitals and surgical centers, oncology centers, clinics, community healthcare, others.

On the basis of Geography,
• North America
• South America
• Europe
• Asia-Pacific
• Middle East & Africa

Competitive Analysis: Global Liquid Biopsy Market

The global liquid biopsy market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of liquid biopsy market for global, Europe, North America, Asia Pacific and South America.

Speak to Author of the report @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-liquid-biopsy-market

Other Report

Global Innovation Management Market – Industry Trends and Forecast to 2024

Global Innovation Management Market, By Geography; Type (Software, Services); Organization Size (Large Enterprises, Small & Medium-sized Enterprises (SMEs)); Deployment Model (On-premises, Cloud); Application (Product Research & Development Platforms, Marketing, Design, Idea Platforms, Collective Intelligence & Prediction Platforms, Human Resource & Freelancers Platforms); Vertical (Banking, Financial Services, Insurance, IT, Media & Communication Technology, Aerospace & Defense, Public Sector & Education, Healthcare & Pharmaceuticals, Retail & Consumer Goods, Automotive & Manufacturing, Transportation & Logistics) – Industry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/global-innovation-management-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.